The C-terminal domain of perfringolysin O is an essential
cholesterol-binding unit targeting to cholesterol-rich microdomains
Yukiko Shimada
1
, Mikako Maruya
2
, Shintaro Iwashita
3
and Yoshiko Ohno-Iwashita
1
1
Biomembrane Research Group, Tokyo Metropolitan Institute of Gerontology;
2
Department of Cell Biology, Tokyo Metropolitan
Institute of Medical Science;
3
Mitsubishi Kagaku Institute of Life Sciences (MITILS), Machida, Tokyo, Japan
There is much evidence to indicate that cholesterol forms
lateral membrane microdomains (rafts), and to suggest their
important role in cellular signaling. However, no probe has
been produced to analyze cholesterol behavior, especially
cholesterol movement in rafts, in real time. To obtain a
potent tool for analyzing cholesterol dynamics in rafts, we
prepared and characterized several truncated fragments of
h-toxin (perfringolysin O), a cholesterol-binding cytolysin,
whose chemically modified form has been recently shown to
bind selectively to rafts. BIAcore and structural analyses
demonstrate that the C-terminal domain (domain 4) of the
toxin is the smallest functional unit that has the same cho-
lesterol-binding activity as the full-size toxin with structural
stability. Cell membrane-bound recombinant domain 4 was
detected in the floating low-density fractions and was found
to be cofractionated with the raft-associated protein Lck,
indicating that recombinant domain 4 also binds selectively
to cholesterol-rich rafts. Furthermore, an enhanced green
fluorescent protein-
1domain 4 fusion protein stains mem-
brane surfaces in a cholesterol-dependent manner in living
cells. Therefore, domain 4 of h-toxin is an essential choles-
terol-binding unit targeting to cholesterol in membrane rafts,
providing a very useful tool for further studies on lipid rafts
on cell surfaces and inside cells.
Keywords: raft; microdomain; cholesterol; BIAcore;
perfringolysin O.
In recent years, accumulating evidence has indicated that
cholesterol forms lateral membrane microdomains (lipid
rafts) in which sphingolipids are also enriched [1,2]. This
microdomain is a scaffold where specific proteins assemble
and plays a pivotal role in signal transduction and many
other cellular functions [3]. Lipid rafts have been isolated
by sucrose density gradient centrifugation after treatment
of cells with Triton X-100 (TX-100) by taking advantage of
their insolubility in detergent at 4 C [2]. Changes in
cholesterol content, either by inhibition of its biosynthesis
or by its removal from the plasma membrane, affect the
localization of proteins associated with rafts, and thus
affect raft function [4,5], suggesting (an) essential role(s) of
cholesterol in the structural maintenance and function of
rafts. Although interest in cholesterol functions and
demand for their analyses have been increasing rapidly,
there are almost no probes that have been used to detect
and monitor cholesterol in rafts. Filipin is a reagent
currently used for the cytochemical staining of cholesterol
in fixed cells [6]. However, filipin permeabilizes the cell
membrane and binds to cell cholesterol indiscriminately
[6,7].
We have examined the cytolytic mechanism of perfringo-
lysin O (h-toxin) secreted by Clostridium perfringens,which
binds to membrane cholesterol and causes cell disruption.
Cholesterol-mediated binding to a membrane is a trigger for
forming toxin oligomers, leading to the formation of large
pores. This pore formation directly causes cell membrane
damage resulting in cell disruption. We prepared several
h-toxin derivatives that retain specific binding activity to
cholesterol but lack cytolytic activity. Ch[8] is a protease-
nicked derivative and loses the capacity to oligomerize
below 20 C. MCh[9] and BCh[10,11] are methylated and
biotinylated derivatives of Ch, respectively, and both have
the same binding specificity and affinity for membrane
cholesterol as intact h-toxin, but cause no damage to
membranes at 37 Corbelow.
The h-toxin derivatives bind to liposomes with high
cholesterol content but not to liposomes that contain less
than 20 mol% of cholesterol [12], which strongly suggests
their selective binding to cholesterol-enriched membrane
domains. Recently we demonstrated that BChselectively
binds to cholesterol in cholesterol-rich microdomains of
intact cells, domains that fulfill the criteria of lipid rafts
[7]. The BChbound to various types of cells was found to
be TX-100 insoluble at 4 C[7].WhenBCh-bound
platelets were treated with TX-100 and fractionated on a
sucrose-density gradient, BChwas predominantly localized
in the floating low-density fractions (FLDF) where
cholesterol, sphingomyelin and Src family kinases are
enriched [7]. Depletion of one-third of the cholesterol from
cells with b-cyclodextrin, which was accompanied by more
than a 70% reduction in cholesterol from FLDF, almost
Correspondence to Y. Shimada or Y. Ohno-Iwashita, Biomembrane
Research Group, Tokyo Metropolitan Institute of Gerontology,
35–2 Sakae-cho, Itabashi-ku, Tokyo 173–0015, Japan.
Fax: +81 3 35794776, Tel: +81 3 39643241 ext. 3063 or 3068,
E-mail: yshimada@tmig.or.jp or iwashita@tmig.or.jp
Abbreviations: Br-DSPC, brominated distearoylphosphatidylcholine;
DOPC, dioleoylphosphatidylcholine; DSPC, distearoylphospha-
tidylcholine; EGFP, enhanced green fluorescent protein; FLDF,
floating low-density fractions; IPTG, isopropyl thio-b-
D
-galactoside;
2OHpbCD, 2-hydroxypropyl-b-cyclodextrin; PE, phosphatidyl-
ethanolamine; TX-100, Triton X-100.
(Received 5 August 2002, revised 10 October 2002,
accepted 30 October 2002)
Eur. J. Biochem. 269, 6195–6203 (2002) FEBS 2002 doi:10.1046/j.1432-1033.2002.03338.x
completely abolished BChbinding to lipid rafts. This
indicates that the binding of BChto lipid rafts depends on
their cholesterol content. BCh, coupled with fluorescent-
avidin or colloidal gold-avidin, has been used as a probe
to analyze the distribution of membrane cholesterol by
fluorescence microscopy and electron microscopy
[10,11,13].
Rafts are abundant at the plasma membrane surface, and
are also found in intracellular compartments in the endo-
cytic pathway [14]. In a further study on lipid rafts, analysis
of the dynamic movement of intracellular rafts, for instance
raft assembly and raft trafficking, is necessary as well as that
on the membrane surface. However, as staining with BCh
requires fluorescent avidin, it is not suitable for real-time
imaging of the dynamic movement of lipid rafts in living
cells. Especially, such movement inside the cell is hard to
trace by the indirect fluorescence method. To establish a
system for real-time imaging of rafts, we have attempted to
isolate the cholesterol-binding domain of the toxin. Based
on the 3D crystal structure [15], h-toxin comprises four
b-sheet-rich domains, and only domain 4, located at the
C-terminus, is structurally autonomous [15]. There is
evidence to suggest that a cholesterol-binding site is located
within domain 4. For example, a C-terminal fragment
obtained by trypsin digestion (T2), including predominantly
domain 4, binds to cholesterol and to cholesterol-containing
membranes [16]. Furthermore, experiments with many
toxins mutated in the tryptophan-rich motif at the C-
terminus have revealed a significant reduction in the
membrane-binding activity [17]. However, the cholesterol-
binding site of h-toxin has not been clearly defined as yet.
We have characterized cholesterol binding activity in
relation to toxin stability and identified the smallest region
necessary for its activity. In this paper, we show that
domain 4 of h-toxin is an essential cholesterol-binding unit
targeting to cholesterol in lipid rafts. Furthermore, we
demonstrate that enhanced green fluorescent protein
(EGFP)-tagged domain 4 may be a promising tool for
analyzing raft dynamics in living cells.
EXPERIMENTAL PROCEDURES
Materials
Anti-h-toxin antibody was raised in rabbits as described
previously [16]. A rabbit antibody specific to the C-terminus
of h-toxin was produced using the peptide antigen
CGTTLYPGSSITYN (amino acids C449-N472 of the
mature form of h-toxin). Cholesterol and isopropyl thio-b-
D
-galactoside (IPTG) were purchased from Sigma (St Louis,
MO, USA). Hydroxylapatite was from Seikagaku (Tokyo,
Japan). Peroxidase-conjugated anti-rabbit IgG was pur-
chased from Medical & Biological Laboratories (Nagoya,
Japan). BIAcore sensor chip SA was from BIAcore
(Uppsala, Sweden). Alexa FluorTM 546 was from Molecular
Probes, Inc. (Eugene, OR, USA).
Plasmid construction
Plasmid pNSP10 containing the perfringolysin O gene
(pfoA) [17] was used to construct pfoA derivatives encoding
the C-terminal region of the toxin. The DNA fragment
containing the T2¢(V337-N472)-encoding region was pre-
pared by digesting pNSP10 with SpeIandXhoIand
inserting it between the NheIandXhoIsitesonthe3¢side of
the sequence encoding His-tag and a thrombin-cleavage site
in the expression vector pET-28b. The DNA fragment
containing the D4 (K363-N472)- or DN-D4 (S371-N472)-
encoding region was amplified from pNSP10 by a poly-
merase chain reaction and ligated into pET-28b digested
with NheIandXhoI. The NheI restriction sites of the
polymerase chain reaction-amplified products were created
as noncomplementary ends of the amplification primers.
For DC-D4 (K363-T470), a pNSP10-derived plasmid enco-
ding D471 (K1-T470) was used as a PCR template. The poly-
merase chain reaction primers used were 5¢-CTCAGGC
TAGCAAGGGAAAAATAAACTTAGATC-3¢(for D4
and DC-D4), 5¢-TCAGAGCTAGCAGTGGAGCCTATG
TTGCACAG-3¢(for DN-D4) and 5¢-TGGTGGTGG
TGCTCGAGTGC-3¢. For the construction of a plasmid
encoding a His-tag-EGFP-D4 fusion protein, a DNA frag-
ment containing the EGFP-encoding region was amplified
from pEGFP-N3 (Clontech) by the polymerase chain
reaction with forward primer A (5¢-CGTTCTAGAGT
GAGCAAGGGCGAGGAGCTG-3¢) and reverse primer
B(5¢-ATCTACGTCGGCTAGCCTTGTACAGCTCGT
CCATGCCGAG-3¢). The fragment was then ligated into
the NheI site of the plasmid encoding His-tag-D4. The
DNA sequences in the resulting plasmids were confirmed
by the dideoxynucleotide chain-termination method [18].
Plasmids were introduced into E. coli strain BL21 (DE3)
[19] (Novagen, Madison, WI, USA) by transformation of
competent cells.
Protein production and purification
E. coli strain BL21(DE3) was used for the overexpression of
His-tag-T2¢, His-tag-D4, His-tag-DN-D4 and His-tag-DC-
D4 fusion proteins. After induction with IPTG, E. coli cells
were harvested by centrifugation and lysed in native lysis
buffer (50 m
M
phosphate buffer, pH 8.0, 300 m
M
NaCl,
10 m
M
imidazole) by ultrasonication. The overexpressed
proteins were partially purified from the cytoplasmic
fraction of E. coli by Ni
+
-NTA agarose column chroma-
tography. His-tagged toxin fragments bound to Ni
+
-NTA
agarose were eluted with 250 m
M
imidazole. For further
purification, the fractions containing His-tagged toxin
fragments were loaded onto a hydroxylapatite column
equilibrated with 20 m
M
phosphate buffer, pH 8.0, and the
flow through fraction was collected. Active fragments were
recovered in the flow through fraction, while inactive ones
were adsorbed to hydroxylapatite. The pooled fraction was
incubated with thrombin at an enzyme to substrate ratio of
1 : 100 for 5 h at room temperature to cleave the His-tag
and the cleavage reaction was stopped by the addition of
1m
M
phenylmethanesulfonyl fluoride. After protease treat-
ment, the pooled fraction was applied to a butyl-agarose
column equilibrated with 20 m
M
Tris/HCl, pH 7.5, con-
taining 0.8
M
(NH
4
)
2
SO
4
. The toxin fragments were eluted
with 0.2
M
(NH
4
)
2
SO
4
and dialyzed against Hepes-buffered
saline, pH 7.0, at 4 C. The purity of the toxin fragments
was checked by SDS/PAGE [20]. The sequence GSHMAS
remains attached to the N termini of purified fragments
after thrombin cleavage. Toxin derivatives MChand BCh,
and the T2 fragment were prepared as described previously
[9,10,16].
6196 Y. Shimada et al. (Eur. J. Biochem. 269)FEBS 2002
Binding to cholesterol on TLC plates
The cholesterol-binding activity of each toxin fragment was
examined on TLC plates as described previously [16]. Toxin
fragments bound to the TLC plates were detected with anti-
whole h-toxin antibody.
Preparation of lipid vesicles
Phospholipids [dioleoylphosphatidylcholine (DOPC) or
brominated distearoylphosphatidylcholine (Br-DSPC)]
alone or 1 : 1 (mol/mol) mixtures of cholesterol and
phospholipids were evaporated to make lipid films.
Hepes-buffered saline was added to the lipid films and
mixed vigorously. The lipid dispersion was sonicated with a
Branson Sonifier and centrifuged at 9000 gfor 5 min to
remove undispersed lipids. For kinetic analysis by the
BIAcore system, 0.1 mol% of biotin-phosphatidylethanol-
amine (PE) was added to the lipid mixture before evapor-
ation. The lipid dispersion containing biotin-PE was frozen
and thawed 10 times, and the resultant multilamellar
vesicles were extruded through 100 nm polycarbonate
membranes in a Liposofast apparatus (Avestin Inc.,
Ottawa, Canada).
Binding of toxin fragments to liposomes and MOLT-4
cells
The toxin fragments were incubated individually with
liposomes in Hepes-buffered saline containing 1 mgÆmL
)1
bovine serum albumin for 30 min at room temperature. The
mixtures were centrifuged at 350 000 gfor 30 min at 4 C.
Both the pellets and the supernatants were analyzed by
Western blotting using anti-C-terminal peptide antibody.
For measurement of binding to cultured cells, MOLT-4
(10
5
cells) [21] were washed twice with phosphate-buffered
saline (NaCl/P
i
), and then incubated with or without 5 m
M
2-hydroxypropyl-b-cyclodextrin (2OHpbCD) in serum-free
RPMI 1640 for 15 min at 37 C. The cells were then washed
twice with NaCl/P
i
, and then incubated with toxin frag-
ments (0.3 lg) in NaCl/P
i
containing 1 mgÆmL
)1
bovine
serum albumin for 30 min at 37 C. Toxin fragments bound
to cells were obtained in the pellet by centrifugation.
Measurement of Trp fluorescence
A 0.3 nmol sample of each purified toxin fragment was
mixed with either phospholipid-liposomes [toxin fragment/
phospholipids 1 : 30 (mol/mol)] or cholesterol/phospho-
lipid-liposomes [toxin fragment/cholesterol 1 : 30 (mol/mol)]
in 1.5 mL of Hepes-buffered saline. After incubation for
10 min at room temperature, emission spectra were recor-
ded in the range of 300–400 nm at an excitation wavelength
of 295 nm with a Shimadzu spectrofluorophotometer
RF-5000.
Circular dichroism spectra
Circular dichroism spectra were recorded on a JASCO
J-720 spectropolarimeter with 5 mm pathlength cells. Toxin
fragments in NaCl/P
i
were scanned from 250 to 200 nm.
Molecular ellipticity ([h]) was calculated based on the mean
residue weight of each fragment.
Kinetic analysis of toxin fragments in cholesterol
binding
The cholesterol-binding kinetics of toxin fragments were
determined by surface plasmon resonance [22] using BIA-
core 1000TM. All experiments were carried out at 25 Cin
degassed Hepes-buffered saline. DOPC/cholesterol lipo-
somes containing biotin-PE were injected and immobilized
on a sensor chip SA that has dextran matrix-attached
streptavidin. After immobilization, the final signal increase
was 1000 response units (RU). MCh,T2¢and D4 were
dialyzed against the same buffer and applied to the
liposome-immobilized sensor chip. Analyses were per-
formed at a flow rate of 20 lLÆmin
)1
. Another sensor chip
SA bearing immobilized DOPC/biotin-PE liposomes was
used as a control.
Susceptibility of toxin fragments to a protease
Liposome-bound toxin fragments were obtained by ultra-
centrifugation after incubation with liposomes as described
above. Subtilisin BPN¢was mixed with toxin fragment or
liposome-bound toxin fragment preparations in 50 m
M
phosphate buffer, pH 7.0. The mixture was incubated for
30 min at 27 C and the cleavage reaction was stopped by
the addition of phenylmethanesulfonyl fluoride at a final
concentration of 1 m
M
.
TX-100 treatment and sucrose density gradient
fractionation
In order to isolate TX-100-insoluble membranes, MOLT-4
cells were extracted on ice for 20 min with 1% TX-100 in
TNE buffer (25 m
M
Tris/HCl, pH 7.5, 150 m
M
NaCl,
5m
M
EDTA) containing 2 m
M
phenylmethanesulfonyl
fluoride, 1 m
M
leupeptin, 25 lgÆmL
)1
aprotinin and
20 lgÆmL
)1
soybean trypsin inhibitor. Then the TX-100-
soluble and -insoluble fractions were separated by centri-
fugation at 15 000 gfor 15 min and analyzed by Western
blotting. For sucrose density gradient fractionation,
TX-100-treated cells were homogenized with a Potter–
Elvehjem homogenizer and mixed with an equal volume of
80% sucrose, overlaid with 2.4 mL of 35% sucrose and
1.3 mL of 5% sucrose in TNE buffer. After centrifugation
at 250 000 gfor 18 h at 4 C in a SW55 rotor, 11 fractions
of 0.4 mL each were collected from the top and the pellet
was suspended in 0.4 mL of TNE buffer.
Fluorescence microscopy
For fluorescence microscopic observation, EGFP-D4 was
overexpressed in E. coli and purified with Ni
+
-NTA
agarose as described for the purification of the T2¢and
D4 fragments. The fractions eluted from the Ni
+
-NTA
agarose column were applied to a butyl-agarose column
equilibrated with 20 m
M
Tris/HCl, pH 7.5, containing
0.8
M
(NH
4
)
2
SO
4
. EGFP-D4 was eluted with 20 m
M
Tris/
HCl, pH 7.5. Cells were incubated with EGFP-D4 in
serum-free RPMI-1640 for 5 min at 37 C. After washing
with RPMI 1640, fluorescence images of living cells were
observed using an Olympus fluorescent microscope. No
significant difference in cell viability was found before and
after EGFP-D4 addition by checking with trypan blue
FEBS 2002 A probe for raft cholesterol in living cells (Eur. J. Biochem. 269) 6197
exclusion. More than 95% of the cells were viable after
being labeled with EGFP-D4, washed and incubated for
one hour at room temperature.
Others
Tricine-SDS/PAGE was performed by the method of
Schagger [23]. N-terminal sequences of toxin fragments
were analyzed with a precise cLC protein sequencer
(Applied Biosystems) according to the manufacturer’s
recommendations.
RESULTS
Isolation of cholesterol-binding fragments of h-toxin
As the C-terminal portion of h-toxin might retain choles-
terol binding activity, several N-terminal truncated frag-
ments were constructed and expressed in E. coli.Toxin
fragments T2¢,D4,DN-D4, and DC-D4 [Fig. 1(A)] were
purified from the cytoplasmic fraction of E. coli by
Ni
+
-NTA agarose, hydroxylapatite and butyl agarose
column chromatographies. We also prepared the T2
fragment [16] and a toxin derivative, MCh[9], from
recombinant h-toxin protein by biochemical modification
as described before. Three fragments (T2, T2¢and D4) were
obtained as single proteins [Fig. 1(B)]. On the other hand,
DN-D4, which is truncated by eight-amino acids from the N
terminus of domain 4, and DC-D4, which has only two
amino acids deleted from the C terminus of domain 4, were
not stable during the purification process. Therefore small
amounts of the DN-D4 and DC-D4 fragments were
recovered. N-terminal sequence analysis of the T2¢and
D4 fragments revealed that they have the expected
N-terminal sequence.
Binding specificity and affinity of toxin fragments
for cholesterol
We first examined the binding specificity of the toxin
fragments to cholesterol by immunostaining with anti-h-
toxin antibody on lipid-developed TLC plates. The T2¢and
D4 fragments, as well as T2 and MCh, bound only to free
cholesterol among lipids [Fig. 2(A)], indicating specific
recognition of free cholesterol by these toxin fragments. To
investigate the binding specificity to cholesterol as a mem-
brane component further, liposomes containing cholesterol
were prepared. After incubation with DOPC/cholesterol
liposomes, the T2¢and D4 fragments were detected in the
pellet fraction [Fig. 2(B)], which shows that the fragments
have binding activity similar to those of intact h-toxin, MCh
and T2. Negligible amounts of toxin fragments were bound
to liposomes prepared without cholesterol, indicating the
specific binding for cholesterol in membranes. These results
show that cholesterol-binding activity resides in domain 4,
and the binding specificity is the same as that of h-toxin.
They also indicate that the amino acid sequence of whole
domain 4 is required for folding into a stable structure
for cholesterol binding. As expected, neither T2¢nor D4
showed hemolytic activity (data not shown) despite of their
ability to bind to cholesterol-containing membranes.
We next examined the cholesterol-binding kinetics of
these toxin fragments by surface plasmon resonance using a
sensor chip on which cholesterol-containing liposomes were
immobilized (Table 1). Association and dissociation rate
constants for T2¢and D4 binding to cholesterol-containing
liposomes were almost the same as corresponding constants
for MChbinding (Table 1), indicating that the deletion of
domains 1–3 from the toxin did not influence the binding
kinetics. As a result, the dissociation constants also exhibit
similar values. These experiments with liposomal mem-
branes show that domain 4 retains the same binding
specificity and binding affinity for membrane cholesterol
as h-toxin.
Protease susceptibility of membrane-bound toxin
fragments
To investigate the state of the toxin fragments during
membrane binding, we analyzed the susceptibilities of the
T2¢and D4 fragments to protease in the presence and
absence of membranes (Fig. 3). In the absence of liposomal
Fig. 1. Isolation of toxin fragments. (A) Schematic drawings of h-toxin
and its derivatives. Recombinant toxin fragments T2¢,D4,DN-D4 and
DC-D4 were produced in E. coli with an N-terminal His-tag for
purification. After thrombin digestion, an extra of six amino acids
remained at the N terminus of each fragment (dotted rectangles). T2 is
a tryptic fragment of h-toxin and the N-terminal sequence was deter-
mined previously [8]. Amino acid numbers shown in each toxin
derivative correspond to the positions in h-toxin. The black rectangles
represent the tryptophan-rich motif in domain 4. The arrowhead
indicates the position of a protease-nicked site located between T144
and H145 in MChand BCh. (B) SDS/PAGE of purified toxin frag-
ments and derivatives. Toxin fragments (T2¢and D4) were expressed in
E. coli and purified from the cytoplasmic fraction by a series of column
chromatographies as described in Experimental procedures. MChand
T2 were obtained from recombinant h-toxin by biochemical modifi-
cations as described before. Lane M shows molecular size marker
proteins.
6198 Y. Shimada et al. (Eur. J. Biochem. 269)FEBS 2002
membranes, both fragments were digested by subtilisin
BPN¢into undetectable pieces (Fig. 3, lanes 2 and 6). When
the D4 fragment bound to DOPC/cholesterol liposomes
was treated with subtilisin BPN¢, no changes in fragment
size were observed on Tricine-SDS/PAGE (Fig. 3, lane 8).
In the case of T2¢, after binding to DOPC/cholesterol
liposomes, subtilisin BPN¢digestion produced a proteolytic
fragment with a molecular size similar to that of the D4
fragment (Fig. 3, lane 4). The resultant proteolytic frag-
ments were recovered from the gel (lanes 4 and 8) and their
N-terminal sequences were analyzed by a protein sequencer.
The N-terminal amino acid sequence of the liposome-
bound D4 fragment after digestion was found to be
GSHMASKGKI, which corresponds to the N-terminal
sequence of the intact D4 fragment, indicating that no
cleavage occurred. On the other hand, the N-terminal
amino acid sequence of the digested product of the
liposome-bound T2¢fragment was determined to be STE-
YSKGKIN, indicating that 27 amino acid residues were
cleaved from the N terminus of T2¢. The cleaved position is
shown in the 3D structure of the T2¢fragment (Fig. 3),
demonstrating that the entire domain 4 region is protected
from protease digestion. This finding is consistent with the
Fig. 2. Binding of h-toxin fragments to cholesterol. (A) Specific binding
of h-toxin fragments to cholesterol on TLC plates. Lipid mixtures
containing 2 lg each of standard neutral lipids were applied to TLC
plates and the plates were developed. The plates were then incubated
with toxin fragments or derivatives and bound proteins were detected
by immunostaining with anti-(whole h-toxin) Ig. Lipids were detected
with 3% cupric acetate/8% phosphoric acid by heating at 140 C
(lipidslane). PC, phosphatidylcholine; SM, sphingomyelin. (B) Toxin
binding to liposomal membranes. h-Toxin, MChand toxin fragments
were incubated with DOPC liposomes or DOPC/cholesterol liposomes
for 20 min at room temperature. After centrifugation, the total frac-
tion (T), and the resulting supernatant (S) and pellet (P) fractions were
separated and analyzed by SDS/PAGE followed by immunoblotting
with an antibody against h-toxin C-terminal peptide. Lane M shows
molecular size marker proteins.
Table 1. Kinetic analysis of toxin fragment binding to cholesterol by surface plasmon resonance. Kinetic analysis of toxin fragment binding to
immobilized cholesterol-containing liposomes was performed as described in Experimental procedures. The binding kinetics were analyzed by the
software
BIAEVALUATION
2.1. Each value is given as mean ± SE, n¼6.
Toxin fragment k
on
(
M
)1
Æs
)1
)k
off
(s
)1
)K
D
(
M
)
D4 (1.1 ± 0.29) ·10
5
(6.0 ± 0.47) ·10
)3
(5.2 ± 0.14) ·10
)8
T2¢(1.7 ± 0.47) ·10
5
(1.4 ± 0.17) ·10
)2
(8.8 ± 0.30) ·10
)8
MCh(5.1 ± 2.5) ·10
4
(6.5 ± 0.11) ·10
)3
(1.5 ± 0.81) ·10
)7
Fig. 3. Susceptibility of T2¢and D4 to protease. T2¢and D4 fragments
were digested with subtilisin BPN¢in the presence or absence of cho-
lesterol-containing liposomes. After protease treatment, the resultant
fragments were separated by Tricine-SDS/PAGE and analyzed by
Western blotting with an antibody against h-toxin C-terminal peptide.
In the lower panel the 3D structures of T2¢and D4 are shown in black
against a gray background of the whole h-toxin structure. The arrow
indicates the position of cleavage by the protease in the presence of
cholesterol-containing liposomes. The N-terminal sequences of T2¢
and D4 are also shown in the lower panel.
FEBS 2002 A probe for raft cholesterol in living cells (Eur. J. Biochem. 269) 6199